Confirmed Control Announced Transaction verified ConsumerJoint Pain TherapiesLife SciencesNon Opioid Pain Therapeutics
Flexion Therapeutics acquired by Pacira BioSciences
Pacira BioSciences agreed to acquire Flexion Therapeutics, a US life sciences brand, on Oct 11, 2021.
Transaction summary
- Target
- Flexion Therapeutics
- Acquirer
- Pacira BioSciences
- Seller
- -
- Announced
- 2021-10-11
- Geography
- United States
- Tags
- ConsumerJoint Pain TherapiesLife SciencesNon Opioid Pain Therapeutics
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
11x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- A comparable 100% enterprise value has not been established. Separately reported amounts are retained below.
- EV / EBITDA: 11x.
- EBITDA and multiple inputs are not fully disclosed in public transaction materials reviewed; treat the multiple as an estimate.
- EBITDA basis was not stated in the source material.
Source summary
No public source summary has been published for this transaction yet.